Medical Article

The same forces now at play in medical aesthetics will soon appear in every therapeutic category where treatment overlaps with identity, from hormones to nootropics to genetic optimization. The post The GLP-1 Revolution: Medical Aesthetics And The Coming Battle For Control appeared first on MedCity News.

Sponsored by Personify Health, a leader in personalized health platforms, the webinar draws attention to a variety of perspectives, including a CFO, a former CHRO, a chief medical officer and a health benefits research director. The post 5 Takeaways from Personify Health Webinar on Battling Rising Costs of Healthcare appeared first on MedCity News.

The technology already exists that would allow us to close the loop between physiological dysfunction and neural adaptation in real time. The question is not if, but how, rapidly this capability will reshape therapeutic paradigms and the economics that sustain them. The post What If Training the Brain, Not Medicating the Body, Is the Future…

Responsible procurement and handling of data and digital marketing insights by hospitals can generate useful information to improve patient wellness and operational efficiency without compromising compliance. The post Personalize Patient Care with Confidence Through Efficient, HIPAA-Compliant Data Usage appeared first on MedCity News.

At MedCity News’ INVEST Digital Health conference, Sanford Health’s virtual care chief Dave Newman pointed out that in rural America, virtual care often determines whether patients receive treatment at all. He described how Sanford has expanded beyond video visits to include various other modalities like e-visit questionnaires, remote monitoring and even phone consults — saving…

Marlow Hernandez, the founder and former CEO of Cano Health, is facing a jury trial this week over allegations that he fraudulently enriched himself and his family while managing the senior-focused primary care company. Cano filed for bankruptcy last year — an event many industry experts attributed to Hernandez’ poor governance. The post Ex-Cano Health…

Novavax’s partnership with Sanofi allows the pharma giant to explore potential combinations of assets from both companies, and it’s a blueprint for the kinds of alliances the vaccine developer is pursuing. Rather than commercializing vaccines, Novavax aims to turn its research into business development deals, R&D executive Ruxandra Draghia-Akli said. The post Novavax Sees Sanofi…